1. Home
  2. VERA vs PII Comparison

VERA vs PII Comparison

Compare VERA & PII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$42.24

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Logo Polaris Inc.

PII

Polaris Inc.

HOLD

Current Price

$63.68

Market Cap

3.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
VERA
PII
Founded
2016
1954
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Recreational Games/Products/Toys
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.8B
IPO Year
2021
1994

Fundamental Metrics

Financial Performance
Metric
VERA
PII
Price
$42.24
$63.68
Analyst Decision
Strong Buy
Hold
Analyst Count
11
12
Target Price
$76.60
$57.50
AVG Volume (30 Days)
836.9K
861.0K
Earning Date
05-27-2026
04-27-2026
Dividend Yield
N/A
4.37%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$7,152,000,000.00
Revenue This Year
N/A
$1.64
Revenue Next Year
N/A
$4.20
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$18.53
$30.92
52 Week High
$56.05
$75.25

Technical Indicators

Market Signals
Indicator
VERA
PII
Relative Strength Index (RSI) 45.32 44.01
Support Level $40.87 $62.95
Resistance Level $56.05 $66.12
Average True Range (ATR) 1.98 2.37
MACD -0.01 -0.37
Stochastic Oscillator 43.60 28.95

Price Performance

Historical Comparison
VERA
PII

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About PII Polaris Inc.

Polaris designs and manufactures off-road vehicles, including all-terrain vehicles and side-by-side vehicles for recreational and utility purposes, snowmobiles, and on-road vehicles, along with the related replacement parts, garments, and accessories. The firm entered the marine market after acquiring Boat Holdings in 2018, offering exposure to pontoon and deck boat users. It is slated to divest its Indian motorcycle brand to Carolwood in the first quarter of 2026. Polaris products are retailed through more than 2,500 dealers in North America and 1,500 international dealers as well as more than 25 subsidiaries and 90 distributors in more than 100 countries outside North America.

Share on Social Networks: